Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study aims to cut unneeded meds for mental health patients

NCT ID NCT07043803

First seen May 15, 2026 · Last updated May 24, 2026 · Updated 1 time

Summary

This study tests a program to reduce or stop anticholinergic medications in adults with schizophrenia, bipolar disorder, or other serious mental illnesses when these drugs are no longer needed. About 111 participants from UPMC clinics will be guided to taper off these medications safely. The goal is to improve memory and thinking by removing unnecessary drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHIATRIC DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Comprehensive Recovery Services (Pittsburgh) of Western Psychiatric Hospital, Ambulatory Clinics and Residential Programs - UPMC, Pittsburgh, PA

    Pittsburgh, Pennsylvania, 15213, United States

  • UPMC Western Behavioral Health at Safe Harbor

    Erie, Pennsylvania, 16508, United States

  • Western Behavioral Health Mon Yough

    McKeesport, Pennsylvania, 16601, United States

  • Western Behavioral Health of the Alleghenies

    Altoona, Pennsylvania, 16601, United States

Conditions

Explore the condition pages connected to this study.